|
|
|
Pharmaceutical Manufacturing and Packing Sourcer
|
The biopharmaceutical manufacturing sector is adopting new technologies and consumables at a fast pace to meet growth demands and increase flexibility. At the same time, regulatory authorities are putting pressure on biomanufacturers to have control over their full supply chains. Indeed, both manufacturers and industry working groups are placing increased emphasis on raw material and supplier management to help protect patients, enhance transparency and minimise risk (1-4). Additional concerns centre around events that might interrupt the supply of components needed to manufacture human health products.
Some suppliers are responding by investing in strategies, in-house expertise and human and system resources to help biomanufacturers meet these needs, but others are not as responsive. When choosing suppliers, a structured and risk-based approach is important.
A Holistic Approach
Ensuring that materials are available when needed is a key aspect of a supply chain security programme, but it is not sufficient for suppliers to focus on this alone. The products must maintain a high level of quality each time, and any changes must be communicated in a punctual and transparent manner. A comprehensive supply security strategy addresses these needs. One example of a holistic approach is based on three interrelated concepts (see Figure 1).
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
Arquer Diagnostics Appoints Nadia Whittley as CEO
More info >> |
|
 |
White Papers |
 |
|
Clinical Research in Spain
BioClever
This whitepaper is on clinical research in Spain, giving a general outline of the main characteristics of research in this country and an overview of the applicable regulations, along with the reasons why Spain is a good place to do research.
More info >> |
|
 |
Industry Events |
 |
7th annual Orphan Drugs and Rare Diseases UK
18-19 October 2017, Holiday Inn Kensington Forum, London
SMi Group is thrilled to present the 7th annual Orphan Drugs and Rare Diseases conference, taking place on 18th & 19th October 2017 in Central London, UK. This year’s theme will be focused towards discussing strategies for patient engagement, market access and gene therapies to enhance rare diseases and orphan drug research.
More info >> |
|
|
